Ansun Biopharma IPO

ansunbiopharma.com

Ansun Biopharma is a late-stage clinical development company dedicated to saving the lives of vulnerable patient populations through the creation of first-in-class biologics.

Founded2003
Total Funding to Date$165.2MM
Register for Details

For more details on financing and valuation for Ansun Biopharma, register or login.

Please provide your first name.
Please provide your last name.
Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Click here to log in

Ansun Biopharma Ticker Symbol

Ansun Biopharma does not currently have an official ticker symbol because this company is still private. Register today to connect with our Private Market Specialists and learn more about new pre-IPO investment opportunities.

Ansun Biopharma Stock Price

The stock price for Ansun Biopharma will be known as it becomes public. Here are similar public companies: HealthStream (NAS: HSTM), Doximity (NYS: DOCS), Zymergen (NAS: ZY), Sight Sciences (NAS: SGHT).

Ansun Biopharma Funding Rounds and IPO Valuation

Date Funding Round Funding Raised Price per Share IPO Valuation
8/15/2018 Series B $466.82MM $XXX.XX $XXX.XX
5/14/2018 Series A-1 and A-2 $334.66MM $XXX.XX $XXX.XX
Based on primary financings

Other companies like Ansun Biopharma in the Healthcare sector

Sector
Last Round Est. Valuation
$2.15B
Sector
Last Round Est. Valuation
$3.67B
Sector
Last Round Est. Valuation
$334.19MM
Sector
Last Round Est. Valuation
$317.32MM
Sector
Last Round Est. Valuation
$1.08B
Sector
Last Round Est. Valuation
$4.26B
Sector
 
 
Sector
Last Round Est. Valuation
$885.01MM